EyePoint Pharmaceuticals Inc. buy Capital One Financial Co.
Start price
11.12.23
/
50%
€18.40
Target price
11.12.24
€40.94
Performance (%)
-56.86%
End price
12.12.24
€7.94
Summary
This prediction ended on 12.12.24 with a price of €7.94. The BUY prediction by Capital_One_Financia for EyePoint Pharmaceuticals Inc. performed very badly with a performance of -56.86%. Capital_One_Financia has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -13.091% | -13.091% | 53.354% |
| iShares Core DAX® | -0.559% | 0.738% | 14.807% |
| iShares Nasdaq 100 | -0.566% | -0.324% | 3.991% |
| iShares Nikkei 225® | 1.073% | 5.624% | 19.546% |
| iShares S&P 500 | 0.868% | 0.030% | 1.475% |
Comments by Capital_One_Financia for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $44.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Capital_One_Financia gewählte maximale Laufzeit wurde überschritten